Qi-Dong You (QiDong You, Qidong You)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 67

Top Topics

Top Venues

Journal of medicinal chemistry

Journal of the American Chemical Society

Expert opinion on therapeutic patents

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Qiuyue Zhang, Ling Yan, Lixiao Zhang, Jia Yu, Zeyu Han, Hua Liu, Jinying Gu, Keran Wang, Jiayi Wang, Fangsu Chen, Rongde Zhao, Yang Yan, Cheng Jiang, Qi-Dong You, Lei Wang
Allosteric Activation of Protein Phosphatase 5 with Small Molecules. Journal of medicinal chemistry (2024)
Qiuyue Zhang, Ling Yan, Yuxuan Zhang, Lixiao Zhang, Jia Yu, Qi-Dong You, Lei Wang
Rational design of peptide inhibitors targeting HSP90-CDC37 protein-protein interaction. Future medicinal chemistry 16 (2) (2024)
Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry 67 (12) (2024)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qi-Dong You, Lei Wang
Recent developments of HSP90 inhibitors: an updated patent review (2020-present). Expert opinion on therapeutic patents 34 (1-2) (2024)
Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry 67 (12) (2024)
Bing-Yan Li, Pei Li, Lin-Yin Wei, Jia Zou, Yu-Hang Wang, Qi-Dong You, Cheng Jiang, Bin Di, Li-Li Xu
Discovery and Development of NLRP3 Inhibitors Targeting the LRR Domain to Disrupt NLRP3-NEK7 Interaction for the Treatment of Rheumatoid Arthritis. Journal of medicinal chemistry (2024)
Jian'ai Ji, Yuhui Jin, Sinan Ma, Yuxuan Zhu, Xinyu Bi, Qi-Dong You, Zheng-Yu Jiang
Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition. Journal of medicinal chemistry 67 (15) (2024)
Jian'ai Ji, Yuhui Jin, Sinan Ma, Yuxuan Zhu, Xinyu Bi, Qi-Dong You, Zheng-Yu Jiang
Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition. Journal of medicinal chemistry (2024)
Zekun Li, Mochen Guo, Mingxiao Gu, Zhongtian Cai, Qiuyu Wu, Jia Yu, Meilun Tang, Chenxi He, Yuxuan Wang, Piaoyang Sun, Qi-Dong You, Lei Wang
Design and Synthesis of 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid Derivatives as PP5 Inhibitors To Reverse Temozolomide Resistance in Glioblastoma Multiforme. Journal of medicinal chemistry (2024)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qi-Dong You, Lei Wang
Recent developments of HSP90 inhibitors: an updated patent review (2020-present). Expert opinion on therapeutic patents (2024)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qi-Dong You, Lei Wang
Recent developments of HSP90 inhibitors: an updated patent review (2020-present). Expert opinion on therapeutic patents 34 (1-2) (2024)
Qiuyue Zhang, Ling Yan, Yuxuan Zhang, Lixiao Zhang, Jia Yu, Qi-Dong You, Lei Wang
Rational design of peptide inhibitors targeting HSP90-CDC37 protein-protein interaction. Future medicinal chemistry 16 (2) (2024)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qi-Dong You, Lei Wang
Recent developments of HSP90 inhibitors: an updated patent review (2020-present). Expert opinion on therapeutic patents (2024)
Qiuyue Zhang, Ling Yan, Yuxuan Zhang, Lixiao Zhang, Jia Yu, Qi-Dong You, Lei Wang
Rational design of peptide inhibitors targeting HSP90-CDC37 protein-protein interaction. Future medicinal chemistry 16 (2) (2024)
Qiuyue Zhang, Ling Yan, Yuxuan Zhang, Lixiao Zhang, Jia Yu, Qi-Dong You, Lei Wang
Rational design of peptide inhibitors targeting HSP90-CDC37 protein-protein interaction. Future medicinal chemistry (2024)
Jian'ai Ji, Yuhui Jin, Sinan Ma, Yuxuan Zhu, Xinyu Bi, Qi-Dong You, Zheng-Yu Jiang
Discovery of a NCOA4 Degrader for Labile Iron-Dependent Ferroptosis Inhibition. Journal of medicinal chemistry 67 (15) (2024)
Jianfeng Liu, Huangliang Shu, Qinxin Xia, Qi-Dong You, Lei Wang
Recent developments of HSP90 inhibitors: an updated patent review (2020-present). Expert opinion on therapeutic patents 34 (1-2) (2024)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Xian Zhang, Keni Cui, Xiaolu Wang, Yuanyuan Tong, Chihong Liu, Yuechao Zhu, Qi-Dong You, Zheng-Yu Jiang, Xiaoke Guo
Novel Hydrogen Sulfide Hybrid Derivatives of Keap1-Nrf2 Protein-Protein Interaction Inhibitor Alleviate Inflammation and Oxidative Stress in Acute Experimental Colitis. Antioxidants (Basel, Switzerland) 12 (5) (2023)
Mingxiao Gu, Sudan Sun, Qi-Dong You, Lei Wang
Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022. Molecules (Basel, Switzerland) 28 (24) (2023)
Nan-Nan Chen, Han Zhang, Qiang-Sheng Zhu, Ting Zeng, Wei Dai, Ye-Ling Zhou, Guo-Feng Xin, Bei-Duo Wu, Si-Jia Gong, Zheng-Yu Jiang, Qi-Dong You, Xiao-Li Xu
Development of Orally Bioavailable Amidobenzimidazole Analogues Targeting Stimulator of Interferon Gene (STING) Receptor. Journal of medicinal chemistry (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Liwen Hua, Danni Wang, Keran Wang, Yuxuan Wang, Jinying Gu, Qiuyue Zhang, Qi-Dong You, Lei Wang
Design of Tracers in Fluorescence Polarization Assay for Extensive Application in Small Molecule Drug Discovery. Journal of medicinal chemistry (2023)
Yuhui Jin, Jing Fan, Ruyan Wang, Xuanyu Wang, Ning Li, Qi-Dong You, Zheng-Yu Jiang
Ligation to Scavenging Strategy Enables On-Demand Termination of Targeted Protein Degradation. Journal of the American Chemical Society (2023)
Jianai Ji, Sinan Ma, Yuxuan Zhu, Jinglong Zhao, Yuanyuan Tong, Qi-Dong You, Zheng-Yu Jiang
ARE-PROTACs Enable Co-degradation of an Nrf2-MafG Heterodimer. Journal of medicinal chemistry (2023)
Xuetao Chen, Danyan Cao, Chihong Liu, Fanying Meng, Zijian Zhang, Rujun Xu, Yuanyuan Tong, Yabing Xin, Weikun Zhang, Wenjing Kang, Qichao Bao, Jingkang Shen, Bing Xiong, Qi-Dong You, Zheng-Yu Jiang
Discovery of 1 H -Imidazo[4,5- b ]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain. Journal of medicinal chemistry (2023)
Ying-Zhe Wang, Hong-Yu Li, Yan Zhang, Rui-Xin Jiang, Jun Xu, Jing Gu, Zheng Jiang, Zheng-Yu Jiang, Qi-Dong You, Xiao-Ke Guo
Discovery of Pyrazolo[1,5- a ]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML. Journal of medicinal chemistry (2023)
Mingxiao Gu, Sudan Sun, Qi-Dong You, Lei Wang
Forward or Backward: Lessons Learned from Small Molecule Drugs Approved by FDA from 2012 to 2022. Molecules (Basel, Switzerland) 28 (24) (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry (2023)
Hui Li, Sheng-Lie Zhang, Yan-Han Jia, Qian Li, Zi-Wen Feng, Shi-Duo Zhang, Wei Zheng, Ye-Ling Zhou, Lin-Lin Li, Xue-Chun Liu, Ya-Qiong Chen, Hui Peng, Qi-Dong You, Xiao-Li Xu
Imidazo[1,2- a ]Pyridine Derivatives as Novel Dual-Target Inhibitors of ABCB1 and ABCG2 for Reversing Multidrug Resistance. Journal of medicinal chemistry 66 (4) (2023)
Ziquan Zhao, Ruitian Dong, Qi-Dong You, Zheng-Yu Jiang
Medicinal Chemistry Insights into the Development of Small-Molecule Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry (2023)
Qiangsheng Zhu, Nannan Chen, Xinjian Tian, Yeling Zhou, Qi-Dong You, Xiao-Li Xu
Hematopoietic Progenitor Kinase 1 in Tumor Immunology: A Medicinal Chemistry Perspective. Journal of medicinal chemistry 65 (12) (2022)
Xuexuan Wu, Qiuyue Zhang, Yuqi Guo, Hengheng Zhang, Xiaoke Guo, Qi-Dong You, Lei Wang
Methods for the Discovery and Identification of Small Molecules Targeting Oxidative Stress-Related Protein-Protein Interactions: An Update. Antioxidants (Basel, Switzerland) 11 (4) (2022)
Liwen Hua, Qiuyue Zhang, Xinyue Zhu, Ruoning Wang, Qi-Dong You, Lei Wang
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors. Journal of medicinal chemistry 65 (12) (2022)
Wei Liu, Jingsheng Jiang, Yating Lin, Qi-Dong You, Lei Wang
Insight into Thermodynamic and Kinetic Profiles in Small-Molecule Optimization. Journal of medicinal chemistry 65 (16) (2022)
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, Qiuyu Wu, Min Fu, Liwen Hua, Xinyue Zhu, Yuqi Guo, Lianshan Zhang, Qi-Dong You, Lei Wang
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity. Journal of the American Chemical Society (2022)
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, Qiuyu Wu, Min Fu, Liwen Hua, Xinyue Zhu, Yuqi Guo, Lianshan Zhang, Qi-Dong You, Lei Wang
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity. Journal of the American Chemical Society 145 (2) (2022)
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, Qiuyu Wu, Min Fu, Liwen Hua, Xinyue Zhu, Yuqi Guo, Lianshan Zhang, Qi-Dong You, Lei Wang
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity. Journal of the American Chemical Society 145 (2) (2022)
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, Qiuyu Wu, Min Fu, Liwen Hua, Xinyue Zhu, Yuqi Guo, Lianshan Zhang, Qi-Dong You, Lei Wang
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity. Journal of the American Chemical Society 145 (2) (2022)
Zhen Dai, Lu-Yan An, Xiao-Yi Chen, Fan Yang, Ni Zhao, Cui-Cui Li, Ren Ren, Bing-Yan Li, Wei-Yan Tao, Pei Li, Cheng Jiang, Fang Yan, Zheng-Yu Jiang, Qi-Dong You, Bin Di, Li-Li Xu
Target Fishing Reveals a Novel Mechanism of 1,2,4-Oxadiazole Derivatives Targeting Rpn6, a Subunit of 26S Proteasome. Journal of medicinal chemistry 65 (6) (2022)
Changyou Ma, Jian Wu, Lei Wang, Xiaojun Ji, Yebin Wu, Lei Miao, Donghui Chen, Linlin Zhang, Youzhi Wu, Haiwei Feng, Ying Tang, Qiuhua Zhou, Junjie Pei, Xule Yang, Dan Xu, Qi-Dong You, Yuan Xie
Discovery of Clinical Candidate NTQ1062 as a Potent and Bioavailable Akt Inhibitor for the Treatment of Human Tumors. Journal of medicinal chemistry 65 (12) (2022)
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, Qiuyu Wu, Min Fu, Liwen Hua, Xinyue Zhu, Yuqi Guo, Lianshan Zhang, Qi-Dong You, Lei Wang
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity. Journal of the American Chemical Society 145 (2) (2022)
Weilin Chen, Xin Chen, Dongdong Li, Jianrui Zhou, Zheng-Yu Jiang, Qi-Dong You, Xiao-Ke Guo
Discovery of DDO-2213 as a Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia. Journal of medicinal chemistry 64 (12) (2021)
Peng-Ju Zhu, Ze-Zhou Yu, Yi-Fei Lv, Jing-Long Zhao, Yuan-Yuan Tong, Qi-Dong You, Zheng-Yu Jiang
Discovery of 3,5-Dimethyl-4-Sulfonyl-1H-Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral Bioavailability. Journal of medicinal chemistry 64 (15) (2021)
Xin Chen, Junjie Xu, Xianghan Wang, Guanlu Long, Qi-Dong You, Xiao-Ke Guo
Targeting WD Repeat-Containing Protein 5 (WDR5): A Medicinal Chemistry Perspective. Journal of medicinal chemistry 64 (15) (2021)
Qiuyue Zhang, Zhongjiao Fan, Lianshan Zhang, Qi-Dong You, Lei Wang
Strategies for Targeting Serine/Threonine Protein Phosphatases with Small Molecules in Cancer. Journal of medicinal chemistry 64 (13) (2021)
Lei Wang, Qiuyue Zhang, Qi-Dong You
Targeting the HSP90-CDC37-kinase chaperone cycle: A promising therapeutic strategy for cancer. Medicinal research reviews 42 (1) (2021)
Hai-Shan Zhou, Lv-Bin Hu, Han Zhang, Wen-Xin Shan, Yan Wang, Xue Li, Tian Liu, Jing Zhao, Qi-Dong You, Zheng-Yu Jiang
Design, Synthesis, and Structure-Activity Relationships of Indoline-Based Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-Like 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitors. Journal of medicinal chemistry 63 (19) (2020)
Lei Wang, Jingsheng Jiang, Lixiao Zhang, Qiuyue Zhang, Jianrui Zhou, Li Li, Xiao-Li Xu, Qi-Dong You
Discovery and Optimization of Small Molecules Targeting the Protein-Protein Interaction of Heat Shock Protein 90 (Hsp90) and Cell Division Cycle 37 as Orally Active Inhibitors for the Treatment of Colorectal Cancer. Journal of medicinal chemistry 63 (3) (2020)
Zhihong Li, Kaijun Su, Zhensheng Jiang, Yancheng Yu, Qi-Dong You, Xiaojin Zhang
Correction to Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light. Journal of medicinal chemistry 63 (9) (2020)
Xiaojin Zhang, Yonghua Lei, Tianhan Hu, Yue Wu, Zhihong Li, Zhensheng Jiang, Changyong Yang, Lianshan Zhang, Qi-Dong You
Discovery of Clinical Candidate (5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine, an Orally Bioavailable Prolyl Hydroxylase Inhibitor for the Treatment of Anemia. Journal of medicinal chemistry 63 (17) (2020)
Yu-Hui Jin, Meng-Chen Lu, Yan Wang, Wen-Xin Shan, Xuan-Yu Wang, Qi-Dong You, Zheng-Yu Jiang
Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown. Journal of medicinal chemistry 63 (9) (2020)
Meng-Chen Lu, Xian Zhang, Feng Wu, Shi-Jie Tan, Jing Zhao, Qi-Dong You, Zheng-Yu Jiang
Discovery of a Potent Kelch-Like ECH-Associated Protein 1-Nuclear Factor Erythroid 2-Related Factor 2 (Keap1-Nrf2) Protein-Protein Interaction Inhibitor with Natural Proline Structure as a Cytoprotective Agent against Acetaminophen-Induced Hepatotoxicity. Journal of medicinal chemistry 62 (14) (2019)
Lei Wang, Lixiao Zhang, Li Li, Jingsheng Jiang, Zhen Zheng, Jialin Shang, Chengxiang Wang, Weilin Chen, Qichao Bao, Xiao-Li Xu, Zheng-Yu Jiang, Jian Zhang, Qi-Dong You
Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Science advances 5 (9) (2019)
Zhihong Li, Kaijun Su, Zhensheng Jiang, Yancheng Yu, Qi-Dong You, Xiaojin Zhang
Photoactivatable Prolyl Hydroxylase 2 Inhibitors for Stabilizing the Hypoxia-Inducible Factor with Light. Journal of medicinal chemistry 62 (16) (2019)
Han Zhang, Qi-Dong You, Xiao-Li Xu
Targeting Stimulator of Interferon Genes (STING): A Medicinal Chemistry Perspective. Journal of medicinal chemistry 63 (8) (2019)
Zhihong Li, Qi-Dong You, Xiaojin Zhang
Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic Applications. Journal of medicinal chemistry 62 (12) (2019)
Li Li, Lei Wang, Qi-Dong You, Xiao-Li Xu
Heat Shock Protein 90 Inhibitors: An Update on Achievements, Challenges, and Future Directions. Journal of medicinal chemistry 63 (5) (2019)
Fen Jiang, An-Ping Guo, Jia-Chen Xu, Qi-Dong You, Xiao-Li Xu
Discovery of a Potent Grp94 Selective Inhibitor with Anti-Inflammatory Efficacy in a Mouse Model of Ulcerative Colitis. Journal of medicinal chemistry 61 (21) (2018)
Li-Li Xu, Tian Liu, Lei Wang, Li Li, Yu-Feng Wu, Cui-Cui Li, Bin Di, Qi-Dong You, Zheng-Yu Jiang
3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1,2,4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation. Oxidative medicine and cellular longevity 2018 (2018)
Xingsen Wu, Xiang Li, Zhihong Li, Yancheng Yu, Qi-Dong You, Xiaojin Zhang
Discovery of Nonquinone Substrates for NAD(P)H: Quinone Oxidoreductase 1 (NQO1) as Effective Intracellular ROS Generators for the Treatment of Drug-Resistant Non-Small-Cell Lung Cancer. Journal of medicinal chemistry 61 (24) (2018)
Arduino Aleksander Mangoni, Tiziano Tuccinardi, Simona Collina, Jean Jacques Vanden Eynde, Diego Muñoz-Torrero, Rafik Karaman, Carlo Siciliano, Maria Emília Sousa, Katalin Prokai-Tatrai, Jarkko Rautio, Catherine Guillou, Michael Gütschow, Stefania Galdieroa, Hong Liu, Luigi A Agrofoglio, Jean Marc Sabatier, Christopher Hulme, George Kokotos, Qi-Dong You, Paula A C Gomes
Breakthroughs in Medicinal Chemistry: New Targets and Mechanisms, New Drugs, New Hopes-3. Molecules (Basel, Switzerland) 23 (7) (2018)
Yue Wu, Zhensheng Jiang, Zhihong Li, Jing Gu, Qi-Dong You, Xiaojin Zhang
Click Chemistry-Based Discovery of [3-Hydroxy-5-(1 H-1,2,3-triazol-4-yl)picolinoyl]glycines as Orally Active Hypoxia-Inducing Factor Prolyl Hydroxylase Inhibitors with Favorable Safety Profiles for the Treatment of Anemia. Journal of medicinal chemistry 61 (12) (2018)
Zheng-Yu Jiang, Meng-Chen Lu, Qi-Dong You
Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) Inhibition: An Emerging Strategy in Cancer Therapy. Journal of medicinal chemistry 62 (8) (2018)
Li-Li Xu, Tian Liu, Lei Wang, Li Li, Yu-Feng Wu, Cui-Cui Li, Bin Di, Qi-Dong You, Zheng-Yu Jiang
Corrigendum to "3-(1H-Benzo[d]imidazol-6-yl)-5-(4-fluorophenyl)-1, 2, 4-oxadiazole (DDO7232), a Novel Potent Nrf2/ARE Inducer, Ameliorates DSS-Induced Murine Colitis and Protects NCM460 Cells against Oxidative Stress via ERK1/2 Phosphorylation". Oxidative medicine and cellular longevity 2018 (2018)
Xian Zhang, Xiang Li, Zhihong Li, Xingsen Wu, Yue Wu, Qi-Dong You, Xiaojin Zhang
An NAD(P)H:Quinone Oxidoreductase 1 Responsive and Self-Immolative Prodrug of 5-Fluorouracil for Safe and Effective Cancer Therapy. Organic letters 20 (12) (2018)